Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA

NCT07070466 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
40
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Massachusetts General Hospital

Collaborators